Keyphrases
Amyotrophic Lateral Sclerosis
100%
Superoxide Dismutase 1 (SOD1)
100%
Tofersen
100%
Neurofilament
28%
Disease Stabilization
28%
Disease Progression
14%
Gene mutation
14%
Functional Outcome
14%
Clinical Experience
14%
Single Center
14%
Muscle Strength
14%
Functional Recovery
14%
Therapeutic Biomarkers
14%
Neurological Function
14%
Clinical Outcome Measures
14%
Sustained Improvement
14%
Motor Score
14%
Functional Independence
14%
ALSFRS-R
14%
Apparent Disease
14%
Function Preservation
14%
Neuromuscular Rehabilitation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Copper Zinc Superoxide Dismutase
100%
Amyotrophic Lateral Sclerosis
100%
Tofersen
100%
Diseases
100%
Biological Marker
14%
Disease Exacerbation
14%
Observational Study
14%
Convalescence
14%
Neuroscience
Copper Zinc Superoxide Dismutase
100%
Amyotrophic Lateral Sclerosis
100%
Tofersen
100%
Neurofilament
28%
Gene Mutation
14%
Neuromuscular
14%